About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Novel Pharmacologic Treatments for Cardiovascular Disease: A Practical Update

Citation:

US Cardiology Review 2017;11(2):98–104.

Advances in Coronary Physiology: Update for 2017

Citation:

US Cardiology Review 2017;11(2):80–5.

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Citation:

European Cardiology Review 2017;12(2):96.

Inflammation Revisited: Atherosclerosis in The Post-CANTOS Era

Citation:

European Cardiology Review 2017;12(2):89–91